GDC-0980, a novel PI3K/mTOR kinase inhibitor, is effective in HER2 positive gastric cancer (GC) cell lines resistant to Trastuzumab

Authors :: Fortunato Ciardiello
Jole Ventriglia
Giuseppe Tirino
A. Diana
Anna Capasso
F. De Vita
Luca Pompella
Michele Orditura
Angelica Petrillo
Maria Maddalena Laterza
Valentina Belli
B. Savastano
Source :: Annals of Oncology. 27:iv22
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
Kinase
business.industry
Cancer
Hematology
medicine.disease
Trastuzumab
Cell culture
Internal medicine
medicine
business
PI3K/AKT/mTOR pathway
medicine.drug

Tools